Current oncology reportsImmunoconjugatesNeoplasmsDrug DevelopmentAntineoplastic AgentsImmunological
Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions.
Abhishek K Tiwatane, Prakash Y Khandave, Sampada Sharad Kulkarni, Kounosuke Oisaki, Abhay H Pande
Published: 202510.1007/s11912-025-01713-y
Abstract
PURPOSE OF REVIEW: ChemoBodies, also known as Antibody Drug Conjugate (ADCs), are one of the fastest growing classes of biopharmaceuticals with great therapeutic potential in solid and hematological tumors, with 14 US-FDA products till July 2025, and…
Preview only. Read the full abstract at the source